Business Description
Vor Biopharma Inc
NAICS : 325412
SIC : 2834
ISIN : US9290331084
Share Class Description:
VOR: Ordinary SharesDescription
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.91 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 0.45 | |||||
| Debt-to-EBITDA | -0.29 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -13.9 | |||||
| 3-Year EPS without NRI Growth Rate | -11.8 | |||||
| 3-Year FCF Growth Rate | -8.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 17.75 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 65.14 | |||||
| 9-Day RSI | 63.24 | |||||
| 14-Day RSI | 61.19 | |||||
| 3-1 Month Momentum % | -8.69 | |||||
| 6-1 Month Momentum % | -20.1 | |||||
| 12-1 Month Momentum % | -59.03 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.69 | |||||
| Quick Ratio | 4.69 | |||||
| Cash Ratio | 4.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -25.1 | |||||
| Shareholder Yield % | 4.88 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -90.76 | |||||
| ROA % | -66.49 | |||||
| ROIC % | -189.37 | |||||
| 3-Year ROIIC % | -227.59 | |||||
| ROC (Joel Greenblatt) % | -246.04 | |||||
| ROCE % | -76.28 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.93 | |||||
| Price-to-Tangible-Book | 0.94 | |||||
| EV-to-EBIT | -0.32 | |||||
| EV-to-EBITDA | -0.33 | |||||
| EV-to-FCF | -0.38 | |||||
| Price-to-Net-Current-Asset-Value | 2.83 | |||||
| Price-to-Net-Cash | 3.42 | |||||
| Earnings Yield (Greenblatt) % | -312.5 | |||||
| FCF Yield % | -146.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VOR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vor Biopharma Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.64 | ||
| Beta | -0.3 | ||
| 3-Year Sharpe Ratio | -1.12 | ||
| 3-Year Sortino Ratio | -1.3 | ||
| Volatility % | 56.56 | ||
| 14-Day RSI | 61.19 | ||
| 14-Day ATR ($) | 0.091086 | ||
| 20-Day SMA ($) | 0.86824 | ||
| 12-1 Month Momentum % | -59.03 | ||
| 52-Week Range ($) | 0.63 - 3.1399 | ||
| Shares Outstanding (Mil) | 68.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vor Biopharma Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vor Biopharma Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vor Biopharma Inc Frequently Asked Questions
What is Vor Biopharma Inc(VOR)'s stock price today?
The current price of VOR is $0.99. The 52 week high of VOR is $3.14 and 52 week low is $0.63.
When is next earnings date of Vor Biopharma Inc(VOR)?
The next earnings date of Vor Biopharma Inc(VOR) is 2025-03-20 Est..
Does Vor Biopharma Inc(VOR) pay dividends? If so, how much?
Vor Biopharma Inc(VOR) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers